MedTrace Logo

Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease. A Cross Sectional Study in Norway.

NCT01524328 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 460

Last updated 2012-02-01

No results posted yet for this study

Summary

The purpose of this study is to investigate the proportion of use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD). In addition, the reason for, and satisfaction with use of CAM.

Conditions

  • Inflammatory Bowel Diseases

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Bjorn Moum, professor · Oslo University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01524328 on ClinicalTrials.gov